Paper Details

  1. Home
  2. Paper Details

Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.

Author: AliInnocent M, ChedjouJean-Paul, EkolloAristide M, EveheMarie S, FroeschlGuenter, HeumannChristian, MansmannUlrich, MbachamWilfred F, MoyehMarcel N, NdikumValentine N, NgongangEric-Oliver, NjiAkindeh M, OgundahunsiOlumide

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the clinical efficacy, tolerability, and safety of three antimalarial drugs (ASAQ, AL, and DHAP) in children under 10 years old.
Paper Details　
Original Abstract of the Article :
Artemether-lumefantrine and artesunate-amodiaquine are first-line treatment for uncomplicated malaria in Cameroon. No study has yet compared the efficacy of these drugs following the WHO recommended 42-day follow-up period. The goal of this study was to compare the clinical efficacy, tolerability an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318246/

データ提供：米国国立医学図書館（NLM）

Comparing Anti-Malarial Treatments in Cameroonian Children

This research focuses on the treatment of uncomplicated Plasmodium falciparum malaria, a serious parasitic disease prevalent in many parts of the world. The researchers conducted a randomized trial to compare the efficacy and safety of three anti-malarial drug regimens: artesunate-amodiaquine (ASAQ), artemether-lumefantrine (AL), and dihydroartemisinin-piperaquine (DHAP). They studied children under ten years old in two malaria-endemic regions of Cameroon.

Navigating the Malaria Desert

The researchers embarked on a journey through the desert of malaria research, seeking effective and safe treatments for this debilitating disease. They carefully compared three different drug regimens, providing valuable insights for optimizing treatment strategies. This research highlights the need for ongoing research and evaluation of anti-malarial drugs, ensuring effective and safe treatment approaches for patients.

The Quest for Effective and Safe Treatments

This study exemplifies the ongoing quest for effective and safe treatments for malaria. The researchers carefully compared three drug regimens, demonstrating the importance of ongoing research and evaluation to refine treatment strategies. It's like exploring a desert with a compass – ongoing research is crucial for navigating the challenges of malaria and finding the most effective pathways to treatment.

Dr.Camel's Conclusion

This study contributes to the ongoing efforts to combat malaria, a disease that plagues many regions of the world. The researchers have provided valuable insights into the efficacy and safety of different anti-malarial drug regimens. Their findings highlight the importance of ongoing research and evaluation, ensuring the development of effective and safe treatments for patients battling this challenging disease.
Date :
  1. Date Completed 2015-09-08
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

25626448

DOI: Digital Object Identifier

PMC4318246

Related Literature

Article Analysis
・Side Effects of artemether and lumefantrine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.